HS3ST3B1

Across TCGA pan-cancer cohorts, HS3ST3B1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated HS3ST3B1 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in mesothelioma (MESO), where higher HS3ST3B1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated HS3ST3B1 expression acts as an unfavorable survival marker.

MESO, BLCA, and LUSC are the cancer types where HS3ST3B1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	III,IV	0.077	0.580	<.001	42	view →
BLCA	OS	Median	III,IV	0.052	0.655	<.001	24	view →
LUSC	DFS	Median	II,III,IV	0.199	0.748	.006	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

HS3ST3B1–MESO (OS)

Open the MESO breakdown →